{"anticipatedPostingDate":"2027-04","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Predose on Day 1 of Cycles 1, 9, and 12 (Cycle 1 consisted of 21 days, Cycles 9 and 12 consisted of 28 days); and Post-Treatment Week 8","title":"Number of Participants With Anti-daratumumab Antibodies","type":"SECONDARY"}